No. |
薬物名(臨床試験情報から抽出) |
DrugBank |
KEGG DRUG * |
KEGG GENES * |
KEGG PATHWAY |
指定難病告示番号 * |
1 |
111jc101 |
- |
- |
- |
- |
1件: 25 |
2 |
Cidofovir |
Cidofovir |
D00273 |
- |
- |
1件: 25 |
3 |
Cyt107 |
- |
- |
- |
- |
1件: 25 |
4 |
Cytarabine |
Cytarabine |
D00168, D03046, D03637 |
- |
- |
6件: 11, 13, 14, 25, 49, 60 |
5 |
Didanosine |
Didanosine |
D00296 |
- |
- |
2件: 25, 265 |
6 |
Emtricitabine |
Emtricitabine |
D01199 |
- |
- |
4件: 25, 93, 265, 325 |
7 |
Enfuvirtide |
Enfuvirtide |
D02499 |
- |
- |
2件: 25, 265 |
8 |
Filgrastim |
Filgrastim |
D03235 |
1件: CSF3R |
5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
25件: 2, 6, 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 283, 284, 285, 331 |
9 |
Interferon alfa |
Interferon alfa |
D03305 |
2件: IFNAR1, IFNAR2 |
17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
5件: 25, 26, 28, 56, 96 |
10 |
Interferon alfa-2b |
Interferon alfa |
D03305 |
2件: IFNAR1, IFNAR2 |
17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
1件: 25 |
11 |
Interleukin-7 |
- |
- |
- |
- |
1件: 25 |
12 |
Lariam |
Mefloquine |
D04895 |
- |
- |
1件: 25 |
13 |
Mefloquine |
Mefloquine |
D04895 |
- |
- |
1件: 25 |
14 |
Methylprednisolone |
Methylprednisolone |
D00407, D00751, D00979, D05000, D05001, D05002 |
1件: NR3C1 |
1件: Neuroactive ligand-receptor interaction |
36件: 2, 13, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 145, 164, 220, 222, 224, 271, 283, 284, 285, 296 |
15 |
Pembrolizumab |
Pembrolizumab |
D10574 |
1件: PDCD1 |
3件: Cell adhesion molecules (CAMs), PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway |
1件: 25 |
16 |
Prednisolone |
Prednisolone |
D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 |
1件: NR3C1 |
1件: Neuroactive ligand-receptor interaction |
38件: 11, 13, 25, 26, 35, 38, 39, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
17 |
Probenecid |
Probenecid |
D00475 |
- |
- |
1件: 25 |
18 |
Pyvst |
- |
- |
- |
- |
1件: 25 |
19 |
Recombinant human interleukin-7 |
Interleukin-7 |
- |
- |
- |
1件: 25 |
20 |
Tenofovir |
Tenofovir |
D06074 |
- |
- |
5件: 2, 25, 93, 265, 325 |
21 |
Tenofovir-emtricitabine |
Emtricitabine |
D01199 |
- |
- |
1件: 25 |
22 |
Teriflunomide |
Teriflunomide |
D10172 |
1件: DHODH |
2件: Metabolic pathways, Pyrimidine metabolism |
2件: 13, 25 |
23 |
Topotecan |
Topotecan |
D02168, D08618 |
- |
- |
1件: 25 |
24 |
Tysabri |
Natalizumab |
D06886 |
1件: ITGA4 |
14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
3件: 13, 25, 63 |
25 |
Zalcitabine |
Zalcitabine |
D00412 |
- |
- |
1件: 25 |
26 |
Zidovudine |
Zidovudine |
D00413 |
- |
- |
6件: 25, 26, 135, 265, 325, 331 |